# Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke

> **NCT00893867** · PHASE3 · TERMINATED · sponsor: **D-Pharm Ltd.** · enrollment: 446 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** DP-b99
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00893867
- **Lead sponsor:** D-Pharm Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 446 (ACTUAL)
- **Why stopped:** The result of a pre-planned interim futility analysis
- **Last updated:** 2012-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893867, "Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00893867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*